Non-Clinical In-vitro and In-vivo Studies in Drug Development

The process of discovering and developing drugs is intricate involving multiple stages of critical importance, from basic research to FDA approval. sequence of steps involved, namely Fundamental Investigation, Preliminary Development, Clinical Testing, and FDA Submission/Authorization. Each stage incorporates major scientific and regulatory assessments, including lead identification, toxicity studies, pharmacological profiling, and clinical testing, spanning Phases I–III. Additionally, Good Laboratory Practice (GLP), Good Manufacturing Practice (GMP), Good Clinical Practice (GCP) at different stages. systematic flow indicates the significance of iterative feedback loops between stages to guarantee safety, efficacy, and regulatory compliance, ultimately leading to the introduction of secure and efficient treatment options to the market.